Vanessa Álvarez-Vidal
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Vanessa Álvarez-Vidal has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Cristina Domínguez-Lenogue
Asociación de Familiares de Enfermos de Alzheimer de Fisterra e Soneira—Afafes. Cee, 15270 A Coruña, Spain
1 shared publication - César Bugallo-Carrera
Department of Developmental Psychology, University of Santiago de Compostela, 15705 Santiago de Compostela, Spain
1 shared publication - David Facal
Department of Developmental Psychology, University of Santiago de Compostela, Santiago de Compostela, Spain
1 shared publication - José Caamaño Ponte
Medical Department, Sanitas Hospitals, 15004 A Coruña, Spain
1 shared publication - Manuel Gandoy-Crego
Department of Psychiatry, Radiology, Public Health, Nursing and Medicine, Faculty of Nursing, Universidade de Santiago de Compostela, Santiago de Compostela, Spain
1 shared publication
Latest Publications
- Open Access
- 16 December 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (12) , 1721
Neuropsychiatric Symptoms after Liver Transplantation in a 65-Year-Old Male Patient
The development of immunosuppressants has been key for the advancement of solid organ transplant surgery. Specifically, cyclosporine, tacrolimus, or everolimus have significantly increased the survival rate of patients by reducing the risk of a rejection of the transplanted organ and limiting graft-versus-host disease. We report the case of a 65-year-old man who, after undergoing a liver transplantation and receiving an immunosuppressive treatment with cyclosporine and everolimus, presented severe obsessive, psychotic, and behavioral symptoms over the past three years, and describe the pharmacological and non-pharmacological interventions implemented against these symptoms. In this case, the immunosuppressants used have been cyclosporine and, preferably, everolimus. On the other hand, potential adverse reactions to the treatment have been observed, including neuropsychiatric symptoms such as tremor, anxiety, dysthymia, psychosis, and behavioral disorders, which make it necessary to use corrective psychoactive drugs such as benzodiazepines, antidepressants, and antipsychotics, combined with non-pharmacological interventions. A transversal approach, from the medical and psychosocial disciplines, facilitates success in managing neuropsychiatric symptoms after soft organ transplants.
- 16 December 2022
- Published by MDPI AG in Brain Sciences
- Vol. 12 (12) , 1721
Open AccessNeuropsychiatric Symptoms after Liver Transplantation in a 65-Year-Old Male Patient
The development of immunosuppressants has been key for the advancement of solid organ transplant surgery. Specifically, cyclosporine, tacrolimus, or everolimus have significantly increased the survival rate of patients by reducing the risk of a rejection of the transplanted organ and limiting graft-versus-host disease. We report the case of a 65-year-old man who, after undergoing a liver transplantation and receiving an immunosuppressive treatment with cyclosporine and everolimus, presented severe obsessive, psychotic, and behavioral symptoms over the past three years, and describe the pharmacological and non-pharmacological interventions implemented against these symptoms. In this case, the immunosuppressants used have been cyclosporine and, preferably, everolimus. On the other hand, potential adverse reactions to the treatment have been observed, including neuropsychiatric symptoms such as tremor, anxiety, dysthymia, psychosis, and behavioral disorders, which make it necessary to use corrective psychoactive drugs such as benzodiazepines, antidepressants, and antipsychotics, combined with non-pharmacological interventions. A transversal approach, from the medical and psychosocial disciplines, facilitates success in managing neuropsychiatric symptoms after soft organ transplants.